AddBIO
Link├╢ping · Founded 2008
About AddBIO
AddBIO AB has developed Zolidd®, a proprietary bioactive nanoparticle for orthopedic and dental implants that liberates bisphosphonate, a bone enhancement drug.
Company Facts
- Founded: 2008
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.4M
- Last round: Series Unknown (Apr 2012)
- Website: http://addbio.se/
- Phone: +46 0 13 21 00 60
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/addbio-2443758 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.